Opsonization-independent antigen-specific recognition by myeloid phagocytes expressing monoclonal antibodies.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 1 9 2023
pubmed: 1 9 2023
entrez: 1 9 2023
Statut: ppublish

Résumé

This report demonstrates a novel class of innate immune cells designated "variable immunoreceptor-expressing myeloids" (VIREMs). Using single-cell transcriptomics and genome-wide epigenetic profiling, we establish that VIREMs are myeloid cells unrelated to lymphocytes. We visualize the phenotype of B-VIREMs that are capable of genetically recombining and expressing antibody genes, the exclusive hallmark function of B lymphocytes. These cells, designated B-VIREMs, display monoclonal antibody cell surface signatures and regularly circulate in the blood of healthy individuals. Single-cell data reveal clonal expansion of circulating B-VIREMs as a dynamic response to disease stimuli. Live-cell imaging models suggest that B-VIREMs load their own Fc receptors with endogenous antibodies during vesicle transport to the cell surface. A first cloned B-VIREM-derived antibody (Vab1) specifically binds stomatin, a ubiquitous scaffold protein that is strictly expressed intracellularly, allowing Vab1-bearing macrophages to phagocytose cell debris without requiring prior opsonization. Our results suggest important antigen-specific tissue maintenance functionalities in these innate immune cells.

Identifiants

pubmed: 37656789
doi: 10.1126/sciadv.adg1812
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadg1812

Auteurs

Michael Neumaier (M)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.
Mannheim Institute of Innate Immunoscience, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.

Sophie Giesler (S)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.
Department of Medicine I - Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Volker Ast (V)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.
Next Generation Sequencing Core Facility, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.

Mathis Roemer (M)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.

Timo-Daniel Voß (TD)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.
Institute of Nutritional Medicine, Department of Immunology, University of Hohenheim, Stuttgart, Germany.

Eileen Reinz (E)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.

Victor Costina (V)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.

Martin Schmelz (M)

Department of Pain Research, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Elina Nürnberg (E)

Institute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.

Stefanie Nittka (S)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.

Aino-Maija Leppä (AM)

Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ)-Center for Molecular Biology of Heidelberg University (ZMBH) Alliance, Heidelberg, Germany.
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.

Ruediger Rudolf (R)

Institute of Molecular and Cell Biology, Mannheim University of Applied Sciences, Mannheim, Germany.

Andreas Trumpp (A)

Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ)-Center for Molecular Biology of Heidelberg University (ZMBH) Alliance, Heidelberg, Germany.
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.

Tina Fuchs (T)

Institute for Clinical Chemistry, University Medicine Mannheim, Mannheim, Germany.
Mannheim Institute of Innate Immunoscience, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
Next Generation Sequencing Core Facility, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.

Classifications MeSH